MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) announced the development of AI-powered fatigue recognition technology that analyzes voice patterns, intended to be added as a commercial feature to the company's Edge AI Intoxication Detection Kiosks. This expansion marks a significant advancement in voice-based diagnostics for identifying impairment in high-risk environments.
The fatigue detection module is designed for industries such as aviation, road transport, and mining, where operator alertness is critical for safety. It complements MindBio's broader platform that already targets intoxication and neurological impairment detection. Initial commercial testing of the kiosk platform is expected in late second quarter 2026.
According to the company, the AI prediction model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy using only the human voice. The enterprise platform includes Edge-AI kiosks integrating bespoke hardware and software for detecting drug and alcohol intoxication in various enterprise environments, including mining, aviation, construction, and law enforcement.
The addition of fatigue detection underscores MindBio's commitment to enhancing workplace safety through non-invasive, rapid screening tools. By analyzing voice patterns, the technology can identify signs of fatigue that may impair judgment and reaction times, potentially preventing accidents.
For more details, the full press release is available at https://nnw.fm/WWgcb. Further updates on MBQIF can be found in the company's newsroom at https://nnw.fm/MBQIF.
This development is particularly relevant as industries seek advanced technologies to monitor employee fitness for duty. Voice-based diagnostics offer a quick and non-invasive alternative to traditional testing methods, potentially improving compliance and safety outcomes. The integration of fatigue detection into existing intoxication kiosks could provide a comprehensive solution for employers.
MindBio Therapeutics Corp. is a biotechnology company commercializing AI prediction technologies for drug and alcohol intoxication detection via voice analysis. The company is developing an enterprise platform that includes Edge-AI kiosks for use in mining, aviation, construction, and law enforcement.
